Betta Pharmaceuticals Co., Ltd. (300558.SZ) SHZ
47.94
-0.39(-0.81%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
47.94
-0.39(-0.81%)
Currency In CNY
Address
No. 355, Xingzhong Road
Hangzhou, 311100
China
Phone
86 571 8613 0357
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1961
First IPO Date
November 09, 2016
| Name | Title | Pay | Year Born |
| Jia Tong | CEO & Director | 0 | 1977 |
| Lieming Ding | Founder, Chairman of the Board, Chief Executive Officer & GM | 0 | 1963 |
| Weisheng Huang | Chief Chemist | 0 | N/A |
| Fei Wu | Supervisor & Senior Director of Internal Control Affairs | 0 | 1977 |
| Yangnan Zhang | Chairman of the Supervisory Board & Senior Director of Project Declaration | 0 | 1971 |
| Jiang Wan | Senior VP, President of Global Sales & Director | 0 | 1968 |
| Mao Li | President of R&D, Chief Medical Officer & Director | 0 | 1957 |
| Lingxi Wu | Board Secretary & Head of Chairman Office | 0 | 1983 |
| Hena Shi | VP, COO & General Manager of Oncology Business Department | 0 | N/A |
| Shi Zhe Ding | Director & Assistant to the Chairman | 0 | 1991 |
| Jianxun Fan | Vice President, Chief Financial Officer & Director | 0 | 1971 |
Betta Pharmaceuticals Co., Ltd. researches and develops, manufactures, and markets medicines for the treatment of cancer in China. The company offers Icotinib hydrochloride, an oral epidermal growth factor receptor tyrosine kinase inhibitor, which is used to treat non-small-cell lung cancer; and Ensartinib hydrochloride, an anaplastic lymphoma kinase inhibitor for the treatment of non-small cell lung cancer. Betta Pharmaceuticals Co., Ltd. was founded in 2003 and is headquartered in Hangzhou, China.